115 related articles for article (PubMed ID: 18951881)
1. Nitric oxide synthases are crucially involved in the development of the severe cardiomyopathy of caveolin-1 knockout mice.
Wunderlich C; Schober K; Kasper M; Heerwagen C; Marquetant R; Ebner B; Forkmann M; Schoen S; Braun-Dullaeus RC; Schmeisser A; Strasser RH
Biochem Biophys Res Commun; 2008 Dec; 377(3):769-74. PubMed ID: 18951881
[TBL] [Abstract][Full Text] [Related]
2. Chronic NOS inhibition prevents adverse lung remodeling and pulmonary arterial hypertension in caveolin-1 knockout mice.
Wunderlich C; Schmeisser A; Heerwagen C; Ebner B; Schober K; Braun-Dullaeus RC; Schwencke C; Kasper M; Morawietz H; Strasser RH
Pulm Pharmacol Ther; 2008; 21(3):507-15. PubMed ID: 18226570
[TBL] [Abstract][Full Text] [Related]
3. The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endothelium.
Wunderlich C; Schober K; Schmeisser A; Heerwagen C; Tausche AK; Steinbronn N; Brandt A; Kasper M; Schwencke C; Braun-Dullaeus RC; Strasser RH
J Mol Cell Cardiol; 2008 May; 44(5):938-47. PubMed ID: 18417152
[TBL] [Abstract][Full Text] [Related]
4. Interaction of caveolin-1, nitric oxide, and nitric oxide synthases in hypoxic human SK-N-MC neuroblastoma cells.
Shen J; Lee W; Li Y; Lau CF; Ng KM; Fung ML; Liu KJ
J Neurochem; 2008 Oct; 107(2):478-87. PubMed ID: 18717816
[TBL] [Abstract][Full Text] [Related]
5. Disruption of caveolin-1 leads to enhanced nitrosative stress and severe systolic and diastolic heart failure.
Wunderlich C; Schober K; Lange SA; Drab M; Braun-Dullaeus RC; Kasper M; Schwencke C; Schmeisser A; Strasser RH
Biochem Biophys Res Commun; 2006 Feb; 340(2):702-8. PubMed ID: 16380094
[TBL] [Abstract][Full Text] [Related]
6. Control of blood pressure variability in caveolin-1-deficient mice: role of nitric oxide identified in vivo through spectral analysis.
Desjardins F; Lobysheva I; Pelat M; Gallez B; Feron O; Dessy C; Balligand JL
Cardiovasc Res; 2008 Aug; 79(3):527-36. PubMed ID: 18349137
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 is important for nitric oxide-mediated angiogenesis in fibrin gels with human umbilical vein endothelial cells.
Pan YM; Yao YZ; Zhu ZH; Sun XT; Qiu YD; Ding YT
Acta Pharmacol Sin; 2006 Dec; 27(12):1567-74. PubMed ID: 17112410
[TBL] [Abstract][Full Text] [Related]
8. Caveolin-1 deficiency increases cerebral ischemic injury.
Jasmin JF; Malhotra S; Singh Dhallu M; Mercier I; Rosenbaum DM; Lisanti MP
Circ Res; 2007 Mar; 100(5):721-9. PubMed ID: 17293479
[TBL] [Abstract][Full Text] [Related]
9. NOS2 deficiency increases intestinal metabolism both in nonstimulated and endotoxemic mice.
Vissers YL; Hallemeesch MM; Soeters PB; Lamers WH; Deutz NE
Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G747-51. PubMed ID: 14656712
[TBL] [Abstract][Full Text] [Related]
10. Targeted mutation of Cav-1 alleviates the effect of endotoxin in the inhibition of ET-1-mediated eNOS activation in the liver.
Kwok W; Clemens MG
Shock; 2010 Apr; 33(4):392-8. PubMed ID: 19730165
[TBL] [Abstract][Full Text] [Related]
11. Role of nitric oxide produced by constitutive and inducible nitric oxide synthases in the mouse gastric fundus.
Arab HA; Hassanpour H; Bozorgi A
Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1038-42. PubMed ID: 18505451
[TBL] [Abstract][Full Text] [Related]
12. Orexin-A-induced feeding is dependent on nitric oxide.
Farr SA; Banks WA; Kumar VB; Morley JE
Peptides; 2005 May; 26(5):759-65. PubMed ID: 15808906
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide-dependent Src activation and resultant caveolin-1 phosphorylation promote eNOS/caveolin-1 binding and eNOS inhibition.
Chen Z; Bakhshi FR; Shajahan AN; Sharma T; Mao M; Trane A; Bernatchez P; van Nieuw Amerongen GP; Bonini MG; Skidgel RA; Malik AB; Minshall RD
Mol Biol Cell; 2012 Apr; 23(7):1388-98. PubMed ID: 22323292
[TBL] [Abstract][Full Text] [Related]
14. Endothelial nitric oxide synthase activation contributes to post-exercise hypotension in spontaneously hypertensive rats.
Lee SK; Kim CS; Kim HS; Cho EJ; Joo HK; Lee JY; Lee EJ; Park JB; Jeon BH
Biochem Biophys Res Commun; 2009 May; 382(4):711-4. PubMed ID: 19306842
[TBL] [Abstract][Full Text] [Related]
15. Small artery remodeling and erythrocyte deformability in L-NAME-induced hypertension: role of transglutaminases.
Pistea A; Bakker EN; Spaan JA; Hardeman MR; van Rooijen N; VanBavel E
J Vasc Res; 2008; 45(1):10-8. PubMed ID: 17898543
[TBL] [Abstract][Full Text] [Related]
16. [Using NO-synthase inhibitors derived from L-arginine for preventing acute experimental lung edema development in mice].
Torkunov PA; Shabanov PD
Eksp Klin Farmakol; 2009; 72(2):44-6. PubMed ID: 19441729
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 ablation reduces the adverse cardiovascular effects of N-omega-nitro-L-arginine methyl ester and angiotensin II.
Pojoga LH; Romero JR; Yao TM; Loutraris P; Ricchiuti V; Coutinho P; Guo C; Lapointe N; Stone JR; Adler GK; Williams GH
Endocrinology; 2010 Mar; 151(3):1236-46. PubMed ID: 20097717
[TBL] [Abstract][Full Text] [Related]
18. Endothelium negatively modulates the vascular relaxation induced by nitric oxide donor, due to uncoupling NO synthase.
Bonaventura D; Lunardi CN; Rodrigues GJ; Neto MA; Vercesi JA; de Lima RG; da Silva RS; Bendhack LM
J Inorg Biochem; 2009 Oct; 103(10):1366-74. PubMed ID: 19699534
[TBL] [Abstract][Full Text] [Related]
19. Coronary flow regulation in mouse heart during hypercapnic acidosis: role of NO and its compensation during eNOS impairment.
Heintz A; Damm M; Brand M; Koch T; Deussen A
Cardiovasc Res; 2008 Jan; 77(1):188-96. PubMed ID: 18006478
[TBL] [Abstract][Full Text] [Related]
20. Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice.
Schubert W; Frank PG; Woodman SE; Hyogo H; Cohen DE; Chow CW; Lisanti MP
J Biol Chem; 2002 Oct; 277(42):40091-8. PubMed ID: 12167625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
